| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
B DNA Binding1
Department of Dermatology [G. K., G. M., G. P., P. K.] and Institute for Anesthesiology [A. G.], Ludwig-Maximilians University of Munich, 80337 Munich, Germany
Inducibility and regulation of the pleiotropic cytokine interleukin 6 (IL-6) upon photodynamic therapy (PDT) was studied in the epithelial cell line HeLa. Photofrin-mediated photosensitization resulted in a rapid and dose-dependent induction of IL-6 mRNA production. Maximal levels were reached after 4 h and had decreased to baseline levels after 24 h. This photochemical induction of IL-6 transcription was followed by a strong secretion of IL-6 protein. In comparison to stimulation by 12-O-tetradecanoylphorbol-13-acetate, the kinetics of IL-6 mRNA and protein synthesis after PDT were delayed, although the maximal amounts of secreted IL-6 protein were comparable. As compared to UV irradiation, on the other hand, PDT-induced IL-6 protein levels were 2- to 10-fold higher and were detectable 4 h earlier. Several potentially relevant regulatory DNA elements of the IL-6 promoter were analyzed by gel retardation assays for PDT-induced protein binding. Interestingly, increased AP-1 DNA binding was detected only at the distal AP-1-specific motif and not at the proximal site, differing in 1 bp. Binding of c-Fos-containing AP-1 heterodimers to the specific motif was up-regulated 30 min after PDT, reaching maximal activity at 4 h. This PDT-induced AP-1 activation was independent from protein kinase C activity. Photosensitization did not induce increased binding at the well-characterized NF-
B element, nor at the multiple cytokine- and second messenger-responsive element of the IL-6 promoter. By analyzing the molecular mechanisms of IL-6 up-regulation upon PDT, we provide evidence for regulatory differences compared to UV light, ionizing irradiation, or stimulation by phorbol ester. Furthermore, this study suggests that the "proinflammatory" cytokine IL-6 might be involved in the inflammatory reaction and subsequent immunological antitumor responses.
1 This investigation was supported by a Grant 0706903A5 from the Bundesministerium für Forschung und Technologie (to A. G.) and the Dr. Bodo Sponholz Stiftung (Frankfurt, Germany) and is part of the doctoral thesis of G. K.
2 To whom requests for reprints should be addressed, at Dermatologische Klinik der Ludwig-Maximilians, University of Munich, Frauenlobstr. 9-11, 80337 Munich, Germany.
3 Present address: Institute for Anesthesiology, Ludwig-Maximilians University of Munich, Marchioninistr. 15, 81377 Munich, Germany.
Received 1/17/95. Accepted 4/ 5/95.
This article has been cited by other articles:
![]() |
J. Xie, H. Pan, S. Yoo, and S.-J. Gao Kaposi's Sarcoma-Associated Herpesvirus Induction of AP-1 and Interleukin 6 during Primary Infection Mediated by Multiple Mitogen-Activated Protein Kinase Pathways J. Virol., December 15, 2005; 79(24): 15027 - 15037. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Henderson, S. O. Gollnick, J. W. Snyder, T. M. Busch, P. C. Kousis, R. T. Cheney, and J. Morgan Choice of Oxygen-Conserving Treatment Regimen Determines the Inflammatory Response and Outcome of Photodynamic Therapy of Tumors Cancer Res., March 15, 2004; 64(6): 2120 - 2126. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Moss Patient Responses to Cytoluminescent Therapy (R) for Cancer: An Investigative Report of Early Experiences and Adverse Effects of an Unconventional Form of Photodynamic Therapy Integr Cancer Ther, December 1, 2003; 2(4): 371 - 389. [Abstract] [PDF] |
||||
![]() |
T.-W. Wong, E. Tracy, A. R Oseroff, and H. Baumann Photodynamic Therapy Mediates Immediate Loss of Cellular Responsiveness to Cytokines and Growth Factors Cancer Res., July 1, 2003; 63(13): 3812 - 3818. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hess, H. Smola, U. Sandaradura de Silva, D. Hadaschik, D. Kube, S. E. Baldus, U. Flucke, and H. Pfister Loss of IL-6 Receptor Expression in Cervical Carcinoma Cells Inhibits Autocrine IL-6 Stimulation: Abrogation of Constitutive Monocyte Chemoattractant Protein-1 Production J. Immunol., August 15, 2000; 165(4): 1939 - 1948. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Granville, C. M. Carthy, H. Jiang, J. G. Levy, B. M. McManus, J.-Y. Matroule, J. Piette, and D. W. C. Hunt Nuclear factor-kappa B activation by the photochemotherapeutic agent verteporfin Blood, January 1, 2000; 95(1): 256 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Korbelik and G. J. Dougherty Photodynamic Therapy-mediated Immune Response against Subcutaneous Mouse Tumors Cancer Res., April 1, 1999; 59(8): 1941 - 1946. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Wierenga, M. Walchner, G. Kick, M. L. Kapsenberg, E. H. Weiss, and G. Messer Evidence for suppressed activity of the transcription factor NFAT1 at its proximal binding element P0 in the IL-4 promoter associated with enhanced IL-4 gene transcription in T cells of atopic patients Int. Immunol., February 1, 1999; 11(2): 297 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Quay, W. Reed, J. Samet, and R. B. Devlin Air Pollution Particles Induce IL-6 Gene Expression in Human Airway Epithelial Cells via NF-kappa B Activation Am. J. Respir. Cell Mol. Biol., July 1, 1998; 19(1): 98 - 106. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |